Veterinary Molecular Diagnostics Market is Expected To Be Worth US$ 123.5 by 2026

Nov 8, 2018

PCR kits segment dominates the market with a market value of US$ 63 Mn in 2017. The segment is expected to maintain its dominance over the forecast period with a market value of US$ 123.5 by 2026 end and expands at a significant CAGR.

November 8, 2018 —

New York, November 08, 2018: PCR kits segment dominates the market with a market value of US$ 63 Mn in 2017. The segment is expected to maintain its dominance over the forecast period with a market value of US$ 123.5 by 2026 end and expands at a significant CAGR.

Market Research Engine has published a new report titled as “Veterinary Molecular Diagnostics Market Size, By Product (PCR kits, INAAT kits, Microarray kits and DNA sequencing kits), By Disease Type (Ana plasma spp., Ehrlichia spp., New Castle Disease, Influenza, Porcine Reproductive & Respiratory Syndrome (PRRS) and others.), By Species (Aquatic, Bovine, Porcine, Ovine, Poultry and Equine), By End-User (veterinary hospitals, clinical laboratories and veterinary research institutes.) By Region, Market Analysis Report, Forecast 2018-2024.”

Browse Full Report: https://www.marketresearchengine.com/veterinary-molecular-diagnostics-market

The potential for developing high specificity molecular diagnostic kits has been attained by initiating mass producing of molecular diagnostic kits for vast veterinary applications. Properly designed genetic assays, acceptable controls, and tough take a look at elucidation, are essential for getting accuracy and hyperbolic specificity altogether polymer based mostly molecular testing. Leading firms within the veterinary molecular medical specialty business are actively producing varied diagnostic kits and reagents to manage and stop animal diseases. However, bound manual handling errors touching clinical effectivity of molecular tests specificity and high prices of veterinary molecular kits and reagents limit the adoption of animal molecular testing over alternative diagnostic procedures like diagnostic imaging, immunodiagnostics, clinical chemistry and others.

Global Veterinary Molecular Diagnostics Market is segmented based on the product as, PCR kits, INAAT kits, Microarray kits and DNA sequencing kits. On the basis of disease type, the market has been segmented into Anaplasma spp., Ehrlichia spp., New Castle Disease, Influenza, Porcine Reproductive & Respiratory Syndrome (PRRS) and others. Based on species type, the market has been segmented into livestock animals including Aquatic, Bovine, Porcine, Ovine, Poultry and Equine. The report segments global Veterinary Molecular Diagnostics Market based on end-use as hospitals, clinical laboratories and veterinary research institutes.

Global Veterinary Molecular Diagnostics Market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional Veterinary Molecular Diagnostics Market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

Competitive Rivalry

 

Global Veterinary Molecular Diagnostics Market share consists of several players including IDEXX Laboratories, Inc., ABAXIS, Inc., VCA, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Zoetis, Inc., GE Healthcare, Heska Corporation, ID. Vet, Virbac, Veterinary Molecular Diagnostics, Inc., and AGFA Healthcare.

Veterinary Molecular Diagnostics Market has been segmented as below:

Veterinary Molecular Diagnostics Market, By Product

PCR kits
INAAT kits
Microarray kits
DNA sequencing kits

Veterinary Molecular Diagnostics Market, By Disease Type

Anaplasma spp.
Ehrlichia spp.
New Castle Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Others

Veterinary Molecular Diagnostics Market, By Species

Livestock Animals

Aquatic
Bovine
Porcine
Ovine
Poultry
Equine

Companion Animals

Canine
Feline
Avian

Veterinary Molecular Diagnostics Market, By End-User

Veterinary Hospitals
Clinical Laboratories
Veterinary Research Institutes

 

Veterinary Molecular Diagnostics Market, By Region

North America
Europe
Asia Pacific
Rest of World

The report covers:

Global Veterinary Molecular Diagnostics Market estimates & forecast from 2015 to 2024, with CAGR for 2018-2024.
Comparative market size analysis for 2017 & 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
Global Veterinary Molecular Diagnostics Market trends, with detailed analysis on consumer trends & manufacturer trends
Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors
Key areas of investments identifying market opportunities and challenges in forecast timeframe
Competitive analysis of the industry players along with the overview on strategic management
Comprehensive company profiles of the major industry players

Report scope:

The global Veterinary Molecular Diagnostics Market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.

The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include IDEXX Laboratories, Inc., ABAXIS, Inc., VCA, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Zoetis, Inc., GE Healthcare, Heska Corporation, ID. Vet, Virbac, Veterinary Molecular Diagnostics, Inc., and AGFA Healthcare.

Reasons to Buy this Report:

Gain comprehensive insights on the industry trends
Identify industry opportunities and key growth segments
Obtain complete market study on the Veterinary Molecular Diagnostics Market
Facilitate strategy planning for your company based on the industry dynamics
Evaluate your competitor’s business segments and portfolios

Request Sample Report from here: https://www.marketresearchengine.com/veterinary-molecular-diagnostics-market

Table of Contents:

Introduction
Research Methodology
Executive Summary
Market Overview

4.1. Introduction

4.2. Drivers

4.2.1. Emergence of advanced veterinary molecular diagnostic tools over traditional diagnostic.

4.2.2. Growing focus on adopted pet's and livestock's health and nutrition

4.3. Restraints

4.3.1. High costs associated with these techniques

4.4. Opportunities

4.5. Challenges

Veterinary Molecular Diagnostics Market, By Product
Veterinary Molecular Diagnostics Market, By Disease Type
Veterinary Molecular Diagnostics Market, By Species
Veterinary Molecular Diagnostics Market, By End-Use
Competitive Landscape
Company Profile

10.1. bioMérieux SA

10.2. IDEXX Laboratories, Inc.

10.3. Thermo Fisher Scientific Inc.

10.4. Qiagen N.V.

10.5. Neogen Corporation

Other Related Market Research Reports:

Yacht Charter Market to Grow at a CAGR of 8.05% By 2024

Keloid Treatment Market Analysis, Trend, Segmentation and Opportunities Forecast To 2024

Contact Info:
Name: John Bay
Email: Send Email
Organization: Market Research Engine

For more information, please visit https://www.marketresearchengine.com/

Release ID: 440452

More News

Australian shares inch higher as caution reigns
Oct 9, 2026
Australian shares inch higher as caution reigns

Shares clocked a second week of modest progress, as global bond yields, stubborn oil prices and local economic woes cap investor confidence.

Oliver Curtis’ bid to float Firmus for $44 billion falls over
Oct 8, 2026
Oliver Curtis’ bid to float Firmus for $44 billion falls over

Firmus has dropped its bid to list on the ASX, leaving its data centre plans to be funded through private markets.

City’s lively streets ‘sealed deal’ as luxury fragrance retailer buys $10.7m Little Collins store
Oct 8, 2026
City’s lively streets ‘sealed deal’ as luxury fragrance retailer buys $10.7m Little Collins store

Fragrance retailer, Prestige Brands, has splashed out $10.75 million on an empty three-storey building.

Why it’s time for you to ditch taking long annual holidays
Oct 8, 2026
Why it’s time for you to ditch taking long annual holidays

There’s a better way of getting the most out of your holidays and it involves taking more frequent but shorter breaks.

ABC hopes embarrassing radio U-turn will deliver ratings dividend
Oct 8, 2026
ABC hopes embarrassing radio U-turn will deliver ratings dividend

In this week’s On Background, an about-face from ABC Radio Sydney, billionaire philanthropist Judith Neilson’s passion project remains stagnant, and media mogul Rupert Murdoch reflects on his legacy – again.

Wes Maas offloads $50m shopping mall as Firmus float fallout hits
Oct 8, 2026
Wes Maas offloads $50m shopping mall as Firmus float fallout hits

It’s been a turbulent week for “Dubbo billionaire” Maas, who is hoping for a big payday from the sale of his Village Southlakes mall.

Wes Maas offloads $50m shopping mall as Firmus float fallout hits
Oct 8, 2026
Wes Maas offloads $50m shopping mall as Firmus float fallout hits

It’s been a turbulent week for “Dubbo billionaire” Maas, who is hoping for a big payday from the sale of his Village Southlakes mall.

’Tis the season for (AI) shortcuts: Inside Coles and Woolies’ fight over Christmas
Oct 8, 2026
’Tis the season for (AI) shortcuts: Inside Coles and Woolies’ fight over Christmas

Australia’s two biggest supermarkets were in agreement on when to hold their Christmas launches this year, but a new battleground has emerged.

ASX finishes lower as oil jumps again on renewed Iran tensions
Oct 8, 2026
ASX finishes lower as oil jumps again on renewed Iran tensions

The Australian sharemarket declined on Thursday as oil prices jumped on renewed Middle East tensions, stoking concerns about inflation. Miners led the losses.

Firmus float in trouble as investors don’t buy the hype
Oct 8, 2026
Firmus float in trouble as investors don’t buy the hype

The Australian data centre operator’s blockbuster landing on the Australian sharemarket is on thin ice as its bankers pull out all stops to convince sceptical buyers.

Aguia builds 30,000t phosphate stockpile in Brazil
Oct 8, 2026
Aguia builds 30,000t phosphate stockpile in Brazil

Aguia Resources has amassed a 30,000-tonne phosphate stockpile at its Três Estradas project and notched up 825t in fresh sales in Brazil as it awaits a key court ruling.

From glowing feedback to undermining: Why has my boss turned on me?
Oct 8, 2026
From glowing feedback to undermining: Why has my boss turned on me?

I asked my manager directly whether I was being pushed out. They were defensive, and said that was just their job.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.